Back

A Paracrine Dietary Lipid Axis Constrains Antitumor Immunity in Liver Cancer

Ciobu, N.; Kumari, R.; Kumar, J. S.; Balaseviciute, U.; Iftesum, M.; Mitchell, J.; Ruiz, J.; Flowers, S.; Nishikawa, K.; Cano-Segarra, G.; Vila-Escoda, A.; Xiao, Y.; Phoebe, A. M.; Navaridas, R.; Steffani, M.; Gannamedi, D. P.; Jin, J.; Cogliati, B.; Saoi, M.; Ly, R.; Ogidigo, J.; Rodriguez-Silva, M.; Pardo, M.; Pokrifka, E.; Almanza, L. A.; Tiano, S.; Bush, E. C.; Nandakumar, R.; Abou-Alfa, G. K.; Pinyol, R.; Monetti, M.; Lombard, D. B.; Bayik, D.; Watson, D. C.; Wang, X.; Jones, P. D.; Stockwell, B. R.; Schwabe, R. F.; Galligan, J. J.; Romesser, P. B.; David, Y.; Gartia, M. R.; Llovet, J. M.

2026-07-09 cancer biology
10.64898/2026.06.25.734592 bioRxiv
Show abstract

Overnutrition-related liver dysfunction and cancer are increasingly prevalent and highly resistant to immunotherapy. While metabolic dysregulation is a hallmark of hepatocellular carcinoma (HCC), how nutrient overload impairs antitumor immunity remains unclear. Here, we show that short-term Western diet (WD) exposure drives near-complete loss of CD8 T cell infiltration and antitumor function in HCC. We identify dietary linoleic acid (LA), the most abundant {omega}-6 fatty acid, as the dominant immunosuppressive driver. Cancer cell-restricted FADS2-mediated desaturation of LA to longer-chain {omega}-6 PUFAs drives their accumulation in the tumor interstitial fluid, suppressing infiltrating CD8 T cells via lipid peroxidation. FADS2 inhibition restores CD8 T cell function and sensitizes WD-driven HCC to PD-1-based immunotherapy. Further, the Parkinsons disease-associated deglycase DJ-1 protects LA-handling proteins from methylglyoxal-mediated glycation, sustaining tumoral immunosuppressive PUFA production. Across multiple independent human MASLD-HCC cohorts, LA metabolic activity correlates with CD8 T cell impairment, immune exclusion, and immunotherapy resistance. Overall, these studies identify a dietary lipid axis as a therapeutically actionable vulnerability in WD-associated HCC.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Nature Communications
5641 papers in training set
Top 16%
11.7%
2
Nature Metabolism
69 papers in training set
Top 0.2%
10.9%
3
Journal of Hepatology
21 papers in training set
Top 0.1%
9.5%
4
Nature
645 papers in training set
Top 2%
6.6%
5
Cell Reports
1498 papers in training set
Top 7%
5.4%
6
Science Advances
1243 papers in training set
Top 9%
3.5%
7
eLife
5828 papers in training set
Top 32%
3.4%
50% of probability mass above
8
Hepatology
22 papers in training set
Top 0.1%
3.4%
9
Gut
40 papers in training set
Top 0.3%
3.2%
10
Cancer Research
130 papers in training set
Top 1%
3.2%
11
Genome Medicine
183 papers in training set
Top 2%
2.7%
12
Gastroenterology
42 papers in training set
Top 0.4%
2.6%
13
Cancer Discovery
66 papers in training set
Top 1%
2.0%
14
JHEP Reports
11 papers in training set
Top 0.1%
1.9%
15
Cellular and Molecular Gastroenterology and Hepatology
46 papers in training set
Top 0.5%
1.9%
16
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 28%
1.7%
17
Nature Cell Biology
118 papers in training set
Top 2%
1.7%
18
Cell Metabolism
57 papers in training set
Top 0.8%
1.5%
19
Journal of Clinical Investigation
179 papers in training set
Top 4%
1.4%
20
Cell Stem Cell
62 papers in training set
Top 1%
1.1%
21
JCI Insight
277 papers in training set
Top 6%
1.1%
22
Cell Reports Medicine
153 papers in training set
Top 3%
1.1%
23
Metabolism
15 papers in training set
Top 0.3%
1.0%
24
Cancer Cell
42 papers in training set
Top 1%
0.9%
25
The EMBO Journal
309 papers in training set
Top 7%
0.8%
26
Nature Genetics
286 papers in training set
Top 5%
0.6%